Assessing management practices for variants of uncertain significance among genetic counselors in pediatrics

Author:

Cheung Chloe12ORCID,Berger Sara M.3,Ross Meredith3,Kramer Tamar3,Li Yuhuan4,Andrews Carli3,Dergham Katia R.35,Spitz Elana36,Florido Michelle E.17,Ahimaz Priyanka13

Affiliation:

1. Genetic Counseling Graduate Program, Vagelos College of Physicians and Surgeons Columbia University New York New York USA

2. Clinical Trials Office Icahn School of Medicine at Mount Sinai New York New York USA

3. Department of Pediatrics, Division of Clinical Genetics, Vagelos College of Physicians and Surgeons Columbia University New York New York USA

4. Department of Biostatistics Columbia University New York New York USA

5. School of Pharmacy and Health Sciences Keck Graduate Insititute Claremont California USA

6. Department of Hematology Oncology University of Carlifornia, Los Angeles Health Los Angeles California USA

7. Department of Genetics and Development, Vagelos College of Physicians and Surgeons Columbia University New York New York USA

Abstract

AbstractIncreased utilization of genomic sequencing in pediatric medicine has increased the detection of variants of uncertain significance (VUS). Periodic VUS reinterpretation can clarify clinical significance and increase diagnostic yield, highlighting the importance of systematic VUS tracking and reinterpretation. There are currently no standardized guidelines or established best practices for VUS management, and our understanding of how genetic counselors (GCs) track and manage VUS results for pediatric patients is limited. In this exploratory study, GCs in pediatric clinics in North America were surveyed about their VUS management practices. A total of 124 responses were included in the analysis. The majority (n = 115, 92.7%) of GCs reported that VUS management workflows were at the discretion of each individual provider in their workplace. Approximately half (n = 65, 52%) kept track of patient VUS results over time, and GCs with lower patient volumes were more likely to do so (p = 0.04). While 95% (n = 114) of GCs had requested VUS reinterpretation at least once, only 5% (n = 6) requested it routinely. Most (n = 80, 86%) GCs notified patients when a VUS was reclassified, although methods of recontact differed when the reclassification was an upgrade versus a downgrade. GCs who asked patients to stay in touch through periodic recontact or follow‐up appointments were more likely to request VUS reinterpretation (p = 0.01). The most frequently reported barriers to requesting reinterpretation regularly were patients being lost to follow‐up (n = 39, 33.1%), insufficient bandwidth (n = 27, 22.9%), and lack of standardized guidelines (n = 25, 21.2%). GCs had consistent overall practices around VUS management around investigation, disclosure, reinterpretation, and recontact, but specific methods used differed and were at the discretion of each provider. These results showcase the current landscape of VUS management workflows in pediatrics and the challenges associated with adopting more uniform practices. The study findings can help inform future strategies to develop standardized guidelines surrounding VUS management.

Funder

National Society of Genetic Counselors

Publisher

Wiley

Subject

Genetics (clinical)

Reference38 articles.

1. 2021 Professional Status Survey: Executive Summary. (2021).https://www.gceducation.org/

2. Challenges of variant reinterpretation: Opinions of stakeholders and need for guidelines

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3